PARJUPAR Study: Bromocriptine, Selegeline or Both Delay the Need of Levodopa Therapy in \"De Novo\" Parkinson\'s Disease Patients

Category Primary study
JournalPersonal communication.
Year Not known
This article has no abstract
Epistemonikos ID: 86c2bce1e830a5d018fd441dd31cfed52fe819a8
First added on: Sep 24, 2017